MAPT and Alzheimer disease: The serum p-tau (S202)/t-tau protein ratio also did not differ among groups (AMC, 0.36 ± 0.03; MCI, 0.45 ± 0.03; Mild-AD, 0.35 ± 0.04, p = 0.799, Figure 1C).